CARA

Cara Therapeutics Stock Price

17.55
0.03 (0.17%)
17.52
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Cara Therapeutics Inc CARA NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 17.52 0.00 0.00 0.00 17.52 07:00:00
Bid Price Ask Price Spread Spread % News
17.52 18.24 0.72 3.95% - -
Stock Trades Traded Volume Average Volume 52 Week Range
1 1 547,772 8.88 - 27.55
Last Trade Time Type Quantity Stock Price Currency
07:00:01 1 $ 17.55 USD

Cara Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 819.87M 46.80M 40.95M $ 19.89M $ - -2.49 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Cara Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CARA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week17.0917.979916.4617.33434,4770.432.52%
1 Month15.6017.979914.7016.49546,5391.9212.31%
3 Months13.7918.6013.559715.70537,9153.7327.05%
6 Months15.0018.608.8815.15528,7372.5216.8%
1 Year21.8027.558.8818.54634,819-4.28-19.63%
3 Years14.9927.558.8816.60820,5022.5316.88%
5 Years12.6428.504.2615.11927,3504.8838.61%

Cara Therapeutics Description

Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.


Your Recent History
NASDAQ
CARA
Cara Thera..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.